Hyperbaric Oxygen Therapy as Potential Therapy for Alzheimer’s Dementia

MedicalResearch.com Interview with:

Dr. Paul Harch MD Clinical Professor and Director of Hyperbaric Medicine LSU Health New Orleans School of Medicine

Dr. Harch

Dr. Paul Harch MD
Clinical Professor and Director of Hyperbaric Medicine
LSU Health New Orleans School of Medicine

MedicalResearch.com: What is the background for this study?

Response: The background is a 30 year clinical experience and investigation in which I explored the effects of low-pressure hyperbaric oxygen therapy (HBOT) on acute, subacute, and chronic neurological conditions.

Beginning with brain-injured Louisiana boxers and commercial divers in the late 1980s I attempted to see if patients with central nervous system disorders could respond to a lower dosing of the drug hyperbaric oxygen therapy than was traditionally used for other wound conditions like diabetic foot wounds, radiation wounds, and decompression sickness (the “bends”).  I was successful with the very first cases after which I expanded this treatment to nearly 90 neurological conditions.  The very first patient was a boxer 23 years after his last bout who was formally diagnosed with dementia pugulistica (dementia from boxing).

Since that time I have treated over 100 patients with cognitive decline or dementia, including 11 Alzheimer’s cases.  Nearly all of the Alzheimer’s and other dementia cases were documented with high-resolution brain blood flow imaging (SPECT).  The present case report was the first Alzheimer’s case that I was able to document with PET metabolic imaging.

Continue reading